Literature DB >> 16081690

Human CD8+ T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation.

Olivier Gasser1, Anna Missiou, Ceylan Eken, Christoph Hess.   

Abstract

Activation and subsequent differentiation of naive CD8+ T cells lead to the development of memory subsets with distinct homing and effector capacities. On nonlymphoid homing subsets, expression of "inflammatory" chemokine receptors (such as CXCR3, CCR5, CX3CR1, and CXCR1) is believed to promote migration into sites of infection/inflammation. Here we show that CXCR1 can be up-regulated to the cell surface within minutes of activating human CD8+ T cells. No concurrent up-regulation of other inflammatory chemokine receptors was observed. Up-regulation of CXCR1 preferentially occurred on central memory CD8+ T cells-that is, cells with a lymph node homing phenotype-and was functionally relevant. Immunofluorescence microscopy showed CXCR1 to be present in intracellular vesicles that do not significantly colocalize with perforin, RANTES (regulated upon activation normal T cell expressed and secreted), or the lysosomal marker CD63. By contrast, partial colocalization with the Golgi marker GM130, the constitutive secretory pathway marker beta2-microglobulin, and the early endosome marker EEA1 was observed. Up-regulation of CXCR1 did not occur after T-cell receptor cross-linking. By contrast, supernatants from activated neutrophils, but not from monocytes or dendritic cells, induced its up-regulation. These results suggest that CD8+ T cells can rapidly adapt their homing properties by mobilizing CXCR1 from a distinct intracellular compartment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081690     DOI: 10.1182/blood-2005-04-1366

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  TcR-induced regulated secretion leads to surface expression of CTLA-4 in CD4+CD25+ T cells.

Authors:  Marta Catalfamo; Xuguang Tai; Tatiana Karpova; James McNally; Pierre A Henkart
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

2.  A multimodal imaging workflow for monitoring CAR T cell therapy against solid tumor from whole-body to single-cell level.

Authors:  Rita Pfeifer; Janina Henze; Katharina Wittich; Andre Gosselink; Ali Kinkhabwala; Felix Gremse; Cathrin Bleilevens; Kevin Bigott; Melanie Jungblut; Olaf Hardt; Frauke Alves; Wa'el Al Rawashdeh
Journal:  Theranostics       Date:  2022-06-13       Impact factor: 11.600

3.  Imaging CAR T-cell kinetics in solid tumors: Translational implications.

Authors:  Matthew S Skovgard; Hocine R Hocine; Jasmeen K Saini; Maxim Moroz; Rebecca Y Bellis; Srijita Banerjee; Aurore Morello; Vladimir Ponomarev; Jonathan Villena-Vargas; Prasad S Adusumilli
Journal:  Mol Ther Oncolytics       Date:  2021-06-12       Impact factor: 6.311

4.  IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cells.

Authors:  Takashi Inozume; Ken-ichi Hanada; Qiong J Wang; James C Yang
Journal:  J Immunother       Date:  2009 Feb-Mar       Impact factor: 4.456

5.  Interleukin-8 is essential for normal urothelial cell survival.

Authors:  Stephanie Tseng-Rogenski; Monica Liebert
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-17

6.  Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.

Authors:  Meichi Hsu; Shih-Yi Wu; Shih-Shin Chang; Ih-Jen Su; Ching-Hwa Tsai; Siao-Jing Lai; Ai-Li Shiau; Kenzo Takada; Yao Chang
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

7.  The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections.

Authors:  Jacob E Kohlmeier; Shannon C Miller; Joanna Smith; Bao Lu; Craig Gerard; Tres Cookenham; Alan D Roberts; David L Woodland
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

8.  Effective elicitation of human effector CD8+ T Cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1.

Authors:  Yoshinori Sato; Sayaka Nagata; Masafumi Takiguchi
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.